Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Income Statement 2018–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 7.4M | 9.5M | 9.8M | 10.9M | 13.4M | 11.4M | 126,955 | 212,328 |
| Gross Profit | 1.1M | 1.3M | 1.3M | 1.3M | 2.3M | 1.7M | 55,888 | 28,765 |
| Profitability | ||||||||
| Operating Income | -3.0M | -1.6M | -2.6M | -291,177 | 1.1M | 1.3M | -275,705 | 59,901 |
| EBITDA | — | — | — | — | — | — | -233,991 | 100,512 |
| Net Income | -3.0M | -1.6M | -2.6M | -355,966 | 751,571 | 1.1M | -246,469 | 26,454 |
| Per Share Data | ||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 2M | 18M | 16M | 14M | 171M | 171M | 103M | 75M |
Bionexus Gene Lab Corp. Income Statement — FAQ
Bionexus Gene Lab Corp. (BGLC) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGLC's income statement history?
The chart and table above show Bionexus Gene Lab Corp.'s income statement by year and by quarter, including the growth rate.